MTOR and glioblastoma: Despite this, we observed a sufficient inhibition of mTOR phosphorylation when treating primary GBM cells with 0.5 nM Torin2, and treatment with Torin2 together with TMZ+AT101/AT101 yielded an increased cytotoxic effect in comparison to treatment with solely TMZ+AT101/AT101.